Consolidated Portfolio Review Corp »

Amgen shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $266k 923 288.02
2023-09-30 $305k 1.1k 268.76
2023-06-30 $233k 1.0k 222.02
2023-03-31 $266k 1.1k 241.75

More positions owned by Consolidated Portfolio Review Corp

Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard World Health Car Etf (VHT)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Equal Weight Us (GSEW)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Vanguard World Consum Stp Etf (VDC)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)

View all positions for Consolidated Portfolio Review Corp

Top funds holding Amgen

Vanguard Group
PRIMECAP Management Company
Charles Schwab Investment Management
Wells Fargo & Company
T. Rowe Price Associates
Royal Bank of Canada
Norges Bank Investment Management
Bank of New York Mellon
Legal & General Group
Bank of America Corporation
UBS Group
Goldman Sachs Group
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Barclays

View all funds holding Amgen